Trial Condition(s):

Liver

Primovist Regulatory Post Marketing Surveillance (PMS)

Bayer Identifier:

14332

ClinicalTrials.gov Identifier:

NCT00924248

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice

Inclusion Criteria
- Patient who take Primovist for liver MRI
Exclusion Criteria
- Patients who belong to the contraindication on the product label

Trial Summary

Enrollment Goal
4358
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Eovist/Primovist (Gadoxetate disodium, BAY86-4873)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, South Korea

Status
Completed
 

Trial Design